bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company advancing early-stage cancer diagnostics and targeted therapeutics, today announced a collaboration with Pictor(r), Inc., a targeted proteomic platform company, to support development and commercialization of bioAffinity Technologies' next-generation diagnostic tests designed to provide a more complete picture of lung i…
Tourism in high-altitude areas and high-altitude outdoor activities have seen a significant increase, and health threats centered around high-altitude pulmonary edema and high-altitude pulmonary hypertension have become increasingly prominent. Hypoxia, as the primary pathogenic trigger, initiates a cascade linking inflammatory responses, oxidative stress, and vascular dysfunction, culminating in …
